Adial Pharmaceuticals, IncEducacional
established a Scientific Advisory Board (SAB) and has appointed
Adial Pharmaceuticals, Inc. today announced that it has established a Scientific Advisory Board (SAB) and has appointed Dr. Giovanni Addolorato, a leading global expert in the field of alcohol use disorder (AUD), as its first member and Chairperson. The SAB will help to guide the Company’s strategy and advance AD04, its lead therapeutic agent for AUD, with Phase 3 trials expected to commence in the first half of 2019.
globenewswire.com/news-release/2018/11/29/1659033/0/en/Adial-Pharmaceuticals-Establishes-Scientific-Advisory-Board-and-Appoints-Global-Thought-Leader-in-the-Field-of-Alcohol-Use-Disorder.html
seekingalpha.com/news/3413224-adial-pharmaceuticals-tonix-pharmaceuticals-among-healthcare-gainers-restoration-robotics
globenewswire.com/news-release/2018/11/29/1659033/0/en/Adial-Pharmaceuticals-Establishes-Scientific-Advisory-Board-and-Appoints-Global-Thought-Leader-in-the-Field-of-Alcohol-Use-Disorder.html
seekingalpha.com/news/3413224-adial-pharmaceuticals-tonix-pharmaceuticals-among-healthcare-gainers-restoration-robotics
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.